Market Updates

Next Pharmaceuticals, Kelatron Sign Supply Agreement

Next Pharmaceuticals, Carlsbad, CA, has signed an exclusive supply agreement with Kelatron, Ogden, UT, for access to its patented Chromulin (U.S. Patent No. 6,689,383) product, which is a water-soluble, bioavailable form of chromium that is ideal for beverage applications and foods targeting any aspect of carbohydrate, protein and fat metabolism. Chromulin features a natural combination of the essential mineral chromium III and the essential amino acid histidine, which was formulated and patented by Dr. Richard Anderson at the USDA.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters